Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma

A. Guidetti, A. Mazzocchi, R. Miceli, E. Paterno, F. Taverna, F. Spina, F. Crippa, L. Farina, P. Corradini, A. M. Gianni, S. Viviani

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences